Dynamic Technology Lab’s Adaptive Biotechnologies ADPT Stock Holding History

Dynamic Technology Lab’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-25,468	Closed	-$296K	–	781
2025 Q2	$296K	Buy	+25,468	New	+$231K	0.04%	687
2025 Q1	–	Sell	-18,585	Closed	-$111K	–	958
2024 Q4	$111K	Sell	18,585 -15,998	-46%	-$88.2K	0.02%	817
2024 Q3	$177K	Buy	+34,583	New	+$151K	0.02%	895
2023 Q4	–	Sell	-25,520	Closed	-$139K	–	998
2023 Q3	$139K	Sell	25,520 -12,538	-33%	-$82.9K	0.01%	834
2023 Q2	$255K	Buy	+38,058	New	+$283K	0.03%	755
2023 Q1	–	Sell	-102,841	Closed	-$786K	–	1040
2022 Q4	$786K	Buy	102,841 +12,816	+14%	+$99.7K	0.08%	420
2022 Q3	$641K	Buy	+90,025	New	+$848K	0.06%	531
2021 Q2	–	Sell	-17,033	Closed	-$686K	–	1088
2021 Q1	$686K	Buy	+17,033	New	+$922K	0.08%	402

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

AAP

Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dynamic Technology Lab's ADPT Position: Q3 2025 in Review

Dynamic Technology Lab sold out of Adaptive Biotechnologies (ADPT) in Q3 2025, closing a stake of 25,468 shares — an estimated $296K sold.

Dynamic Technology Lab first reported a position in ADPT in Q1 2021 and held it in 8 quarters. The position peaked at $786K in Q4 2022. 271 funds tracked by Wall St. Rank hold ADPT as of Q3 2025.

Dynamic Technology Lab reported no remaining Adaptive Biotechnologies position as of Q3 2025 after selling out during the quarter.
Dynamic Technology Lab sold 25,468 Adaptive Biotechnologies shares in Q3 2025, an estimated $296K.
Dynamic Technology Lab first reported a position in Adaptive Biotechnologies in Q1 2021 and held it in 8 quarters.
Dynamic Technology Lab's Adaptive Biotechnologies position peaked at $786K in Q4 2022.
271 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2025.

Based on Dynamic Technology Lab's 13F filing for Q3 2025, filed 13 Nov 2025.